Literature DB >> 27988842

Current developments in cancer care: including the patients' perspective-3rd European Roundtable Meeting (ERTM) June 17, 2016, Berlin, Germany.

O Ortmann1,2, W Rösler3, U Helbig4.   

Abstract

PURPOSE: National Cancer Control Plans (NCCP) are necessary to improve cancer care and reduce mortality. We have reported previously on European institutional health structures and transformation of theoretical health care standards into a practical approach. For the latter consideration of the patients' perspective was considered as highly important and chosen as subject for this meeting.
RESULTS: Several European organizations have realized deficits in this area. They promote equal and timely access to cancer care since current inequities lead to disparities in cancer survival across Europe. Patients' support working groups are focussing on employment issues, financial services, psychosocial screening and support, palliative care and rehabilitation. They also identified cancer research including patients' views as highly important. Workshops during the 3rd European Roundtable Meeting (ERTM) covered the issues transparency in patient care, implementation of new knowledge and decision making in partnership with the patient.
CONCLUSIONS: It was concluded that patient views and perspectives have to be considered during the whole continuum of cancer care. Access to treatment, transparency and including patients into the development process are relevant aspects.

Entities:  

Keywords:  Access to cancer care; Cancer care; Cancer research; National Cancer Control Plan; Patient perspective; Shared decision making; Transparency

Mesh:

Year:  2016        PMID: 27988842     DOI: 10.1007/s00432-016-2320-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  6 in total

1.  Improving cancer care in Europe: Which institutional health structures might be beneficial and why? 1. European Roundtable Meeting (ERTM), 16th May 2014, Berlin, Germany.

Authors:  Olaf Ortmann; U Helbig; J Torode
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-03       Impact factor: 4.553

2.  Improving structural development in oncology: transformation of theoretical health care standards and knowledge into a practical approach -- 2nd European Roundtable Meeting (ERTM), May 8, 2015, Berlin, Germany.

Authors:  O Ortmann; J Torode; U Helbig
Journal:  J Cancer Res Clin Oncol       Date:  2015-10-19       Impact factor: 4.553

3.  The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts.

Authors:  Lonneke V van de Poll-Franse; Nicole Horevoorts; Mies van Eenbergen; Johan Denollet; Jan Anne Roukema; Neil K Aaronson; Ad Vingerhoets; Jan Willem Coebergh; Jolanda de Vries; Marie-Louise Essink-Bot; Floortje Mols
Journal:  Eur J Cancer       Date:  2011-05-27       Impact factor: 9.162

4.  Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.

Authors:  Roberta De Angelis; Milena Sant; Michel P Coleman; Silvia Francisci; Paolo Baili; Daniela Pierannunzio; Annalisa Trama; Otto Visser; Hermann Brenner; Eva Ardanaz; Magdalena Bielska-Lasota; Gerda Engholm; Alice Nennecke; Sabine Siesling; Franco Berrino; Riccardo Capocaccia
Journal:  Lancet Oncol       Date:  2013-12-05       Impact factor: 41.316

5.  An exploratory analysis of the factors leading to delays in cancer drug reimbursement in the European Union: the trastuzumab case.

Authors:  Felipe Ades; Chistelle Senterre; Dimitrios Zardavas; Evandro de Azambuja; Razvan Popescu; Florence Parent; Martine Piccart
Journal:  Eur J Cancer       Date:  2014-10-19       Impact factor: 9.162

6.  Economic burden of cancer across the European Union: a population-based cost analysis.

Authors:  Ramon Luengo-Fernandez; Jose Leal; Alastair Gray; Richard Sullivan
Journal:  Lancet Oncol       Date:  2013-10-14       Impact factor: 41.316

  6 in total
  2 in total

Review 1.  Quality control and improvement of cancer care: what is needed? 4th European Roundtable Meeting (ERTM) May 5th, 2017, Berlin, Germany.

Authors:  Olaf Ortmann; Ulrike Helbig; Julie Torode; Stefan Schreck; Sakari Karjalainen; Manola Bettio; Ulrik Ringborg; Monika Klinkhammer-Schalke; Freddy Bray
Journal:  J Cancer Res Clin Oncol       Date:  2018-04-09       Impact factor: 4.553

Review 2.  Knowledge transfer as a tool towards improvement of cancer care in low- and middle-income countries. 6th European Roundtable Meeting (ERTM), June 14th, 2019, Berlin, Germany.

Authors:  O Ortmann; J Torode; W Schmiegel; C Thomssen; M Hakama; P Basu; U Ringborg; U Helbig
Journal:  J Cancer Res Clin Oncol       Date:  2020-04-08       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.